Cancer-related inflammation (original) (raw)

• Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539–545 (2001). This paper revisits Virchow's legacy and highlights the connections between inflammation and cancer.
  CAS PubMed Google Scholar
• Balkwill, F., Charles, K. A. & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211–217 (2005).
  CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  ADS CAS PubMed PubMed Central Google Scholar
• Karin, M. Nuclear factor-κB in cancer development and progression. Nature 441, 431–436 (2006).
  ADS CAS PubMed Google Scholar
• Koehne, C. H. & Dubois, R. N. COX-2 inhibition and colorectal cancer. Semin. Oncol. 31, 12–21 (2004).
  CAS PubMed Google Scholar
• Flossmann, E. & Rothwell, P. M. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369, 1603–1613 (2007).
  CAS PubMed Google Scholar
• Chan, A. T., Ogino, S. & Fuchs, C. S. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med. 356, 2131–2142 (2007).
  CAS PubMed Google Scholar
• Borrello, M. G. et al. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc. Natl Acad. Sci. USA 102, 14825–14830 (2005). This is the first report that a frequent genetic event that causes cancer in humans (rearrangement of the chromosome on which RET is located, in human papillary thyroid carcinoma) activates an inflammatory transcriptional program in normal cells that is associated with metastatic behaviour.
  ADS CAS PubMed PubMed Central Google Scholar
• De Falco, V. et al. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res. 67, 11821–11829 (2007).
  CAS PubMed Google Scholar
• Xu, K. & Shu, H. K. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res. 67, 6121–6129 (2007).
  CAS PubMed Google Scholar
• Guerra, C. et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11, 291–302 (2007).
  CAS PubMed Google Scholar
• Sparmann, A. & Bar-Sagi, D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447–458 (2004).
  CAS PubMed Google Scholar
• Sumimoto, H., Imabayashi, F., Iwata, T. & Kawakami, Y. The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J. Exp. Med. 203, 1651–1656 (2006).
  CAS PubMed PubMed Central Google Scholar
• Shchors, K. et al. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β. Genes Dev. 20, 2527–2538 (2006).
  CAS PubMed PubMed Central Google Scholar
• Soucek, L. et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nature Med. 13, 1211–1218 (2007).
  CAS PubMed Google Scholar
• Balkwill, F. Cancer and the chemokine network. Nature Rev. Cancer 4, 540–550 (2004).
  CAS Google Scholar
• Kobielak, A. & Fuchs, E. Links between α-catenin, NF-κB, and squamous cell carcinoma in skin. Proc. Natl Acad. Sci. USA 103, 2322–2327 (2006).
  ADS CAS PubMed PubMed Central Google Scholar
• Phillips, R. J. et al. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1α. J. Biol. Chem. 280, 22473–22481 (2005).
  CAS PubMed Google Scholar
• Schioppa, T. et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391–1402 (2003).
  CAS PubMed PubMed Central Google Scholar
• Staller, P. et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425, 307–311 (2003).
  ADS CAS PubMed Google Scholar
• Bierie, B. & Moses, H. L. TGF-β and cancer. Cytokine Growth Factor Rev. 17, 29–40 (2006).
  CAS PubMed Google Scholar
• Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Rev. Immunol. 7, 41–51 (2007).
  CAS Google Scholar
• Voronov, E. et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl Acad. Sci. USA 100, 2645–2650 (2003).
  ADS CAS PubMed PubMed Central Google Scholar
• Grivennikov, S. & Karin, M. Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13, 7–9 (2008).
  CAS PubMed Google Scholar
• Szlosarek, P. W. & Balkwill, F. R. Tumour necrosis factor α: a potential target for the therapy of solid tumours. Lancet Oncol. 4, 565–573 (2003).
  CAS PubMed Google Scholar
• Langowski, J. L. et al. IL-23 promotes tumour incidence and growth. Nature 442, 461–465 (2006).
  ADS CAS PubMed Google Scholar
• Courtois, G. & Gilmore, T. D. Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene 25, 6831–6843 (2006).
  CAS PubMed Google Scholar
• Carbia-Nagashima, A. et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia. Cell 131, 309–323 (2007).
  CAS PubMed Google Scholar
• Mizukami, Y. et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells. Nature Med. 11, 992–997 (2005).
  CAS PubMed Google Scholar
• Rius, J. et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453, 807–811 (2008).
  ADS CAS PubMed PubMed Central Google Scholar
• Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
  CAS PubMed Google Scholar
• Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004). References 31 and 32 provide evidence that NF-κB is an endogenous promoter of colon and liver carcinogenesis. Reference 31 also shows that NF-κB activation in myeloid cells is required for colitis-associated cancer.
  ADS CAS PubMed Google Scholar
• Maeda, S., Kamata, H., Luo, J. L., Leffert, H. & Karin, M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977–990 (2005).
  CAS PubMed Google Scholar
• Garlanda, C. et al. Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 67, 6017–6021 (2007).
  CAS PubMed Google Scholar
• Xiao, H. et al. The Toll–interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26, 461–475 (2007).
  CAS PubMed Google Scholar
• Biswas, S. K. et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages: defective NF-κB and enhanced IRF-3/STAT1 activation. Blood 107, 2112–2122 (2006).
  CAS PubMed Google Scholar
• Saccani, A. et al. p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66, 11432–11440 (2006).
  CAS PubMed Google Scholar
• Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295–303 (1999).
  CAS PubMed Google Scholar
• Wang, T. et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Med. 10, 48–54 (2004).
  PubMed Google Scholar
• Kortylewski, M. et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nature Med. 11, 1314–1321 (2005).
  CAS PubMed Google Scholar
• Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S. & Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today 13, 265–270 (1992).
  CAS PubMed Google Scholar
• Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481–490 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bunt, S. K. et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67, 10019–10026 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727–740 (2001). This paper describes the first genetic evidence that TAMs promote cancer, in a study of a primary breast carcinoma model.
  CAS PubMed PubMed Central Google Scholar
• De Palma, M. et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211–226 (2005).
  CAS PubMed Google Scholar
• Sica, A. & Bronte, V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155–1166 (2007).
  CAS PubMed PubMed Central Google Scholar
• Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549–555 (2002).
  CAS PubMed Google Scholar
• Hagemann, T. et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 176, 5023–5032 (2006).
  CAS PubMed Google Scholar
• Fischer, C. et al. Anti-PlGF inhibits growth of VEGFR-inhibitor-resistant tumors without affecting healthy vessels. Cell 131, 463–475 (2007).
  CAS PubMed Google Scholar
• Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820–827 (2005).
  ADS CAS PubMed PubMed Central Google Scholar
• Shojaei, F. et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450, 825–831 (2007).
  ADS CAS PubMed Google Scholar
• Coussens, L. M. et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382–1397 (1999).
  CAS PubMed PubMed Central Google Scholar
• Lewis, C. E., De Palma, M. & Naldini, L. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin 2. Cancer Res. 67, 8429–8432 (2007).
  CAS PubMed Google Scholar
• Sozzani, S., Rusnati, M., Riboldi, E., Mitola, S. & Presta, M. Dendritic cell-endothelial cell cross-talk in angiogenesis. Trends Immunol. 28, 385–392 (2007).
  CAS PubMed Google Scholar
• Noonan, D. M., De Lerma Barbaro, A., Vannini, N., Mortara, L. & Albini, A. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev. 27, 31–40 (2008).
  PubMed Google Scholar
• Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004).
  CAS PubMed Google Scholar
• Swann, J. B. et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl Acad. Sci. USA 105, 652–656 (2008).
  ADS CAS PubMed PubMed Central Google Scholar
• de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411–423 (2005). This paper shows that in a model of human-papilloma-virus-driven carcinogenesis, adaptive immune responses mediated by B cells coordinate cancer-promoting inflammation.
  CAS PubMed Google Scholar
• Beatson, G. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 2, 104–162, (1896).
  Google Scholar
• Zhu, P. et al. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124, 615–629 (2006).
  CAS PubMed Google Scholar
• Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121–124 (2007). References 60 and 61 show that two classic pathways of cancer promotion, hormones and inflammation, are linked in both liver cancer and prostate cancer.
  ADS CAS PubMed Google Scholar
• Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001).
  ADS CAS PubMed Google Scholar
• Burger, J. A. & Kipps, T. J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 1761–1767 (2006).
  CAS PubMed Google Scholar
• Kaifi, J. T. et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J. Natl Cancer Inst. 97, 1840–1847 (2005).
  CAS PubMed Google Scholar
• Salvucci, O. et al. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res. Treat. 97, 275–283 (2006).
  CAS PubMed Google Scholar
• Kim, J. et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J. Clin. Oncol. 23, 2744–2753 (2005).
  CAS PubMed Google Scholar
• Shields, J. D. et al. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11, 526–538 (2007).
  CAS PubMed Google Scholar
• Kawada, K. et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res. 64, 4010–4017 (2004).
  CAS PubMed Google Scholar
• Shulby, S. A., Dolloff, N. G., Stearns, M. E., Meucci, O. & Fatatis, A. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res. 64, 4693–4698 (2004).
  CAS PubMed Google Scholar
• Burns, J. M. et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201–2213 (2006).
  CAS PubMed PubMed Central Google Scholar
• Zipin-Roitman, A. et al. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res. 67, 3396–3405 (2007).
  CAS PubMed Google Scholar
• Ghadjar, P. et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J. Clin. Oncol. 24, 1910–1916 (2006).
  CAS PubMed Google Scholar
• Kulbe, H. et al. The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 67, 585–592 (2007).
  CAS PubMed PubMed Central Google Scholar
• Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R. & Wilson, J. L. The inflammatory cytokine tumor necrosis factor-α regulates chemokine receptor expression on ovarian cancer cells. Cancer Res. 65, 10355–10362 (2005).
  CAS PubMed Google Scholar
• Bates, R. C. & Mercurio, A. M. Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell 14, 1790–1800 (2003).
  CAS PubMed PubMed Central Google Scholar
• Luo, J. L. et al. Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing maspin. Nature 446, 690–694 (2007).
  ADS CAS PubMed Google Scholar
• Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266 (2006).
  CAS PubMed Google Scholar
• Wyckoff, J. B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649–2656 (2007).
  CAS PubMed Google Scholar
• Robinson-Smith, T. M. et al. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res. 67, 5708–5716 (2007).
  CAS PubMed Google Scholar
• Hagemann, T. et al. Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK. J. Immunol. 175, 1197–1205 (2005).
  CAS PubMed Google Scholar
• Marchesi, F. et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res. 64, 8420–8427 (2004).
  CAS PubMed Google Scholar
• Nickoloff, B. J., Ben-Neriah, Y. & Pikarsky, E. Inflammation and cancer: is the link as simple as we think? J. Invest. Dermatol. 124, x–xiv (2005).
  CAS PubMed Google Scholar
• Hagemann, T. et al. Re-educating tumor-associated macrophages by targeting NF-κB. J. Exp. Med. 205, 1261–1268 (2008). This paper shows that NF-κB activated through the IL-1 receptor and MyD88 signalling pathway maintains the phenotype of TAMs, suggesting that tumour-promoting macrophages might be re-educated by the targeting of NF-κB.
  CAS PubMed PubMed Central Google Scholar
• Dajee, M. et al. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639–643 (2003).
  ADS CAS PubMed Google Scholar
• Coley, W. B. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am. J. Med. Sci. 105, 487–511 (1893).
  Google Scholar
• Apetoh, L. et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Med. 13, 1050–1059 (2007).
  CAS PubMed Google Scholar
• Sato, Y. et al. IL-10 deficiency leads to somatic mutations in a model of IBD. Carcinogenesis 27, 1068–1073 (2006).
  CAS PubMed Google Scholar
• Bielas, J. H., Loeb, K. R., Rubin, B. P., True, L. D. & Loeb, L. A. Human cancers express a mutator phenotype. Proc. Natl Acad. Sci. USA 103, 18238–18242 (2006).
  ADS CAS PubMed PubMed Central Google Scholar
• Gungor, N., Godschalk, R. W. L., Pachen, D. M., Van Schooten, F. J. & Knaapen, A. M. Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase. FASEB J. 21, 2359–2367 (2007).
  PubMed Google Scholar
• Dally, H. et al. Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO −463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int. J. Cancer 102, 530–535 (2002).
  CAS PubMed Google Scholar
• Rao, V. P. et al. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 66, 7395–7400 (2006).
  CAS PubMed Google Scholar
• Mantovani, A. Cancer: an infernal triangle. Nature 448, 547–548 (2007).
  ADS CAS PubMed Google Scholar
• Madhusudan, S. et al. Study of etanercept, a tumor necrosis factor-α inhibitor, in recurrent ovarian cancer. J. Clin. Oncol. 23, 5950–5959 (2005).
  CAS PubMed Google Scholar
• Brown, E. R. et al. A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer. Ann. Oncol. 19, 1340–1346 (2008).
  CAS PubMed Google Scholar
• Harrison, M. L. et al. Tumor necrosis factor α as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. J. Clin. Oncol. 25, 4542–4549 (2007). The paper reports the first clinical evidence that TNF-α could be a target for treating renal-cell carcinoma.
  CAS PubMed Google Scholar
• Weber, D. M. et al. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N. Engl. J. Med. 357, 2133–2142 (2007).
  CAS PubMed Google Scholar
• Bertagnolli, M. M. et al. Celecoxib for the prevention of sporadic colorectal adenomas. N. Engl. J. Med. 355, 873–884 (2006).
  CAS PubMed Google Scholar
• Steinbach, G. et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342, 1946–1952 (2000).
  CAS PubMed Google Scholar